TheBankTodayTheBankTodayTheBankToday
Notification Show More
Font ResizerAa
  • Home
  • Banking
  • Credit Cards
  • Loans
  • Personal Finance
  • Guides
  • Latest Updates
  • Compare Credit Cards
Reading: Anuh Pharma Investors to Receive Bonus Shares on July 15
Share
Font ResizerAa
TheBankTodayTheBankToday
  • Home
  • Banking
  • Credit Cards
  • Loans
  • Personal Finance
  • Guides
  • Latest Updates
  • Compare Credit Cards
Search
  • Home
  • Banking
  • Credit Cards
  • Loans
  • Personal Finance
  • Guides
  • Latest Updates
  • Compare Credit Cards
Have an existing account? Sign In
Follow US

Home » Wallet

NSE Stock result
WalletUPI & Payments

Anuh Pharma Investors to Receive Bonus Shares on July 15

Takendra Verma
Last updated: 08/07/2025 4:50 PM
Takendra Verma
Published: 08/07/2025
Share
SHARE

Investors’ shareholding will increase after receiving bonus shares. Although the share price may drop slightly, the total value of their investment will mostly remain the same.

The bonus shares will have a face value of ₹5, just like the existing shares. These bonus shares will be equal in number to the current holdings – fully paid-up and carrying all rights.

This update has been shared with both BSE and NSE. The company’s NSE code is ANUHPHR, and the BSE code is 506260.

Bonus for Demat Holders:
Investors holding shares in demat form through NSDL or CDSL will automatically receive bonus shares in their demat accounts. This bonus issue shows the company’s growth and its intent to reward shareholders. If you have invested in this company, don’t forget the record date – July 15.

About ANUH PHARMA LIMITED:
ANUH PHARMA LIMITED is an Indian pharmaceutical company that mainly produces Active Pharmaceutical Ingredients (APIs), which are the raw chemicals used to make medicines. The company was established in 1960 by late freedom fighter Shri Jaywantrai Ji Shah.

ANUH PHARMA manufactures the key chemical components that make medicines effective. For instance, the active ingredient in a fever medicine like Paracetamol is known as an API.

The company exports its APIs to countries like the USA, Europe, Latin America, the Middle East, Asia, and also serves the Indian market.

It focuses on making APIs for medicines related to antibiotics, anti-malarial, cardiovascular, and anti-tuberculosis treatments.

The company has a manufacturing unit in Maharashtra, certified with international standards such as WHO-GMP (World Health Organization – Good Manufacturing Practices) and EDQM (European Directorate for the Quality of Medicines).

You Might Also Like

Government Keeps Small Savings Interest Rates unchanged
Nippon India launches Two New Index Funds
5 Amazing Home-Based Businesses You Can Start with Rs 10,000
RBI Increases UPI Lite Wallet and Transaction Limits
ICICI Prudential Introduces Open-Ended Quality Fund Scheme
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Difference Between NEFT and RTGS

Get Latest Updates

Important banking and money updates, delivered without the clutter.
Thank you! You are subscribed. Please check your inbox for the welcome email.

Popular Updates

epfo1
PF Withdrawal Wait Reduced to 2 Months
19/11/2026
Jio Logo img
Jio Rs 123 Recharge Plan Offers 0.5GB Daily Data
19/11/2026
FD6 result
Banks Offer Up to 8.50% Interest on Recurring Deposits
19/11/2026
post office1
Post Office ATM Withdrawal Limit (Know Daily Rules)
19/11/2026
pan card
PAN Aadhaar Link Rules (Check Status, Process and Fees)
19/11/2026

Tags

  • SBI
  • HDFC Bank
  • Bank Of Baroda
  • Central Bank
  • Central Bank Of India
  • register mobile number
  • Pan Card
  • What is Bank?
  • SBI Personal Loan
  • check bank balance

TheBankToday

TheBankToday publishes practical banking, personal-finance and financial-news explainers to help readers understand important updates and services.
Quick Links
  • About
  • Contact
  • Disclaimer
  • Join Us
  • T&C
  • Privacy Policy
  • Customize Interests
Important Links
  • Advertise With Us
  • Advertising Policy
  • Cookie Policy
  • Corrections Policy
  • Editorial Policy
  • Fact-Checking Policy
  • Grievance Redressal

Subscribe Us

Subscribe to our newsletter to get our newest articles instantly!

Thank you! You are subscribed. Please check your inbox for the welcome email.
© 2026 TheBankToday. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?